Manyahi Joel, Majigo Mtebe, Kibwana Upendo, Kamori Doreen, Lyamuya Eligius F
Department of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Infect Prev Pract. 2022 Apr 2;4(2):100212. doi: 10.1016/j.infpip.2022.100212. eCollection 2022 Jun.
Multi-drug resistant (MDR) bacteria pose a major global threat to public-health and are of particular concern to hospitalized intensive care unit (ICU) patients. This study aimed at addressing the burden of MDR and the associated factors at admission to ICU.
This was a cross-sectional study conducted at the ICU of a tertiary hospital in Tanzania. Rectal and anterior nares swabs were collected within 48 hours of ICU admission to screen for extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-PE) and meticillin-resistant (MRSA), respectively.
The proportion of fecal carriage for ESBL-PE at admission to ICU was 54.54% (95% CI, 47.52-61.39), and nasal carriage for MRSA was 9.32% (95%CI, 5.67-14.93). The nasal MRSA colonization (OR = 1.52) and fecal carriage for ESBL-PE (OR=1.38) were more likely in participants who had received antibiotics before ICU admission than not, but association was not statistically significant. Hospitalization for ≥2 days (OR=1.18) was associated with fecal carriage of ESBL-PE, though not statistically significant. Overall, 66% and 73.5% of patients received antibiotics before and upon admission to ICU, respectively. Ceftriaxone, metronidazole and meropenem were commonly prescribed antibiotics. More than 84% of Enterobacterales were resistant to ciprofloxacin and trimethoprim-sulfamethoxazole, and 2.90% were resistant to meropenem. MRSA isolates showed a high rate of resistance to gentamicin and erythromycin.
MDR bacteria are common in patients admitted to ICU. To reduce the risk associated with MDR, we recommend use of simple screening methods to screen for MDR at ICU admission as part of infection control and prevention.
多重耐药(MDR)细菌对全球公共卫生构成重大威胁,尤其受到住院重症监护病房(ICU)患者的关注。本研究旨在探讨ICU入院时MDR的负担及其相关因素。
这是一项在坦桑尼亚一家三级医院的ICU进行的横断面研究。分别在ICU入院48小时内采集直肠和前鼻孔拭子,以筛查产超广谱β-内酰胺酶肠杆菌科细菌(ESBL-PE)和耐甲氧西林金黄色葡萄球菌(MRSA)。
ICU入院时ESBL-PE的粪便携带比例为54.54%(95%CI,47.52-61.39),MRSA的鼻腔携带比例为9.32%(95%CI,5.67-14.93)。在ICU入院前接受过抗生素治疗的参与者中,鼻腔MRSA定植(OR = 1.52)和ESBL-PE的粪便携带(OR = 1.38)比未接受过抗生素治疗的参与者更常见,但关联无统计学意义。住院≥2天(OR = 1.18)与ESBL-PE的粪便携带有关,尽管无统计学意义。总体而言,分别有66%和73.5%的患者在ICU入院前和入院时接受了抗生素治疗。头孢曲松、甲硝唑和美罗培南是常用的抗生素。超过84%的肠杆菌科细菌对环丙沙星和甲氧苄啶-磺胺甲恶唑耐药,2.90%对美罗培南耐药。MRSA分离株对庆大霉素和红霉素的耐药率较高。
MDR细菌在入住ICU的患者中很常见。为降低与MDR相关的风险,我们建议使用简单的筛查方法在ICU入院时筛查MDR,作为感染控制和预防的一部分。